$4.46
-1.77-28.33%
At close: -
$4.53
0.061.43%
After Hours: 7:33 PM EDT
Comments
Loading...
Treace Medical Concepts Stock Guidance | NASDAQ:TMCI | Benzinga
Treace Medical Concepts issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
11/06/2025 | TMCI | Treace Medical Concepts | FY | 2025 | — | — | — | $211.00M | $213.00M | $227.14M | |
08/07/2025 | TMCI | Treace Medical Concepts | FY | 2025 | — | — | — | $224.00M | $230.00M | $227.01M | |
05/08/2025 | TMCI | Treace Medical Concepts | FY | 2025 | — | — | — | $224.00M | $230.00M | $227.53M | |
02/27/2025 | TMCI | Treace Medical Concepts | FY | 2025 | — | — | — | $224.00M | $230.00M | $225.63M | |
01/13/2025 | TMCI | Treace Medical Concepts | FY | 2024 | — | — | — | $209.00M | $209.40M | $207.58M | |
01/13/2025 | TMCI | Treace Medical Concepts | Q4 | 2024 | — | — | — | $68.40M | $68.80M | $67.02M | |
11/05/2024 | TMCI | Treace Medical Concepts | FY | 2024 | — | — | — | $204.00M | $211.00M | $205.97M | |
08/06/2024 | TMCI | Treace Medical Concepts | FY | 2024 | — | — | — | $201.00M | $211.00M | $205.40M | |
05/07/2024 | TMCI | Treace Medical Concepts | FY | 2024 | — | — | — | $201.00M | $211.00M | $222.81M | |
02/27/2024 | TMCI | Treace Medical Concepts | FY | 2024 | — | — | — | $220.00M | $225.00M | $223.16M | |
01/08/2024 | TMCI | Treace Medical Concepts | FY | 2023 | — | — | — | $186.70M | $187.10M | $183.85M | |
01/08/2024 | TMCI | Treace Medical Concepts | Q4 | 2023 | — | — | — | $61.80M | $62.20M | $58.89M | |
11/09/2023 | TMCI | Treace Medical Concepts | FY | 2023 | — | — | — | $182.00M | $186.00M | $194.32M | |
08/08/2023 | TMCI | Treace Medical Concepts | FY | 2023 | — | — | — | $191.00M | $197.00M | $194.06M | |
05/08/2023 | TMCI | Treace Medical Concepts | FY | 2023 | — | — | — | $190.00M | $196.00M | $190.54M | |
03/07/2023 | TMCI | Treace Medical Concepts | FY | 2023 | — | — | — | $187.00M | $193.00M | $174.99M | |
01/09/2023 | TMCI | Treace Medical Concepts | FY | 2022 | — | — | — | $141.20M | $141.70M | $137.01M | |
01/09/2023 | TMCI | Treace Medical Concepts | Q4 | 2022 | — | — | — | $49.10M | $49.60M | $44.80M | |
11/08/2022 | TMCI | Treace Medical Concepts | FY | 2022 | — | — | — | $135.00M | $138.00M | $132.40M | |
08/09/2022 | TMCI | Treace Medical Concepts | FY | 2022 | — | — | — | $130.00M | $134.00M | $131.08M | |
05/05/2022 | TMCI | Treace Medical Concepts | FY | 2022 | — | — | — | $128.00M | $133.00M | $128.47M | |
03/03/2022 | TMCI | Treace Medical Concepts | FY | 2022 | — | — | — | $125.00M | $130.00M | $124.25M | |
01/10/2022 | TMCI | Treace Medical Concepts | Q4 | 2021 | — | — | — | $33.10M | $33.40M | $31.93M | |
01/10/2022 | TMCI | Treace Medical Concepts | FY | 2021 | — | — | — | $94.10M | $94.40M | $92.89M |
FAQ
What is the most recent guidance for Treace Medical Concepts (TMCI)?
There have been no specific sales or earnings guidance reported for Treace Medical Concepts in recent months.
Browse guidance and forecast on all stocks.
